Main clinical and histopathologic features of 97 patients with FL at diagnosis
. | No. (%) . |
|---|---|
| Age older than 60 y | 37 (38) |
| Male sex | 49 (51) |
| Histologic grade | |
| 1 | 24 (25) |
| 2 | 57 (58) |
| 3 | 16 (17) |
| Architectural pattern | |
| Follicular | 83 (86) |
| Follicular and diffuse | 5 (5) |
| Diffuse | 9 (9) |
| B-symptoms | 18 (18) |
| ECOG score more than 1 | 13 (13) |
| Bulky disease | 14 (14) |
| Stage IV | 58 (60) |
| Bone marrow involvement | 64 (66) |
| High serum LDH* | 20 (23) |
| High serum β2m* | 28 (38) |
| FLIPI* | |
| Low risk | 32 (37) |
| Intermediate risk | 23 (27) |
| High risk | 31 (36) |
. | No. (%) . |
|---|---|
| Age older than 60 y | 37 (38) |
| Male sex | 49 (51) |
| Histologic grade | |
| 1 | 24 (25) |
| 2 | 57 (58) |
| 3 | 16 (17) |
| Architectural pattern | |
| Follicular | 83 (86) |
| Follicular and diffuse | 5 (5) |
| Diffuse | 9 (9) |
| B-symptoms | 18 (18) |
| ECOG score more than 1 | 13 (13) |
| Bulky disease | 14 (14) |
| Stage IV | 58 (60) |
| Bone marrow involvement | 64 (66) |
| High serum LDH* | 20 (23) |
| High serum β2m* | 28 (38) |
| FLIPI* | |
| Low risk | 32 (37) |
| Intermediate risk | 23 (27) |
| High risk | 31 (36) |
The numbers of patients for whom data on LDH, β2m, and FLIPI were available were 87, 73, and 86, respectively.